Literature DB >> 10474844

[Transforaminal endoscopic microdiscectomy. Indications and short-term to intermediate-term results].

M Haag1.   

Abstract

101 patients with lumbar disc herniation were treated by transforaminal endoscopic microdiscectomy between 5/94 and 6/97. Caused by technical problems the procedure could not be successfully completed in 3 patients. They must be excluded from the presented study as 9 others, who were lost for follow up. So 89 patients were followed with a median follow-up time of 28 months (15-56 months). 69 patients (78%) were satisfied. 16 patients needed a second operation. In 11 of these 16 patients it was done by an open procedure, in 5 by transforaminal endoscopic microdiscectomy again. 4 of these 5 patients showed a good or satisfying result. As in open procedures the most important prognostic factor is a promptly disappearing radicular leg pain. Only 6 of 61 patients with a radicular leg pain disappearing within one week were reoperated, but 10 of 28, who showed a leg pain persisting longer than one week postoperatively.

Entities:  

Mesh:

Year:  1999        PMID: 10474844     DOI: 10.1007/s001320050392

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  3 in total

1.  Treatment of lumbar disc herniations by interventional fluoroscopy-guided endoscopy.

Authors:  Juergen Reul
Journal:  Interv Neuroradiol       Date:  2014-10-17       Impact factor: 1.610

2.  The "inside out" transforaminal technique to treat lumbar spinal pain in an awake and aware patient under local anesthesia: results and a review of the literature.

Authors:  Satishchandra Gore; Anthony Yeung
Journal:  Int J Spine Surg       Date:  2014-12-01

Review 3.  Transforaminal endoscopic surgery for symptomatic lumbar disc herniations: a systematic review of the literature.

Authors:  Jorm Nellensteijn; Raymond Ostelo; Ronald Bartels; Wilco Peul; Barend van Royen; Maurits van Tulder
Journal:  Eur Spine J       Date:  2009-09-15       Impact factor: 3.134

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.